Study shows early success of a novel drug in treating a rare and chronic blood cancer

A novel treatment for polycythemia vera, a potentially fatal blood cancer, demonstrated the ability to control overproduction of red blood cells, the hallmark of this malignancy and many of its debilitating symptoms in a multi-center clinical trial led by the Icahn School of Medicine at Mount Sinai.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup